Valuation: AstraZeneca PLC

Market Cap 30TCr 26TCr 24TCr 22TCr 43TCr 28,50800Cr 43TCr 2,88800Cr 1,12300Cr 14,01300Cr 1,12400Cr 1,10000Cr 48,28800Cr P/E 2026 *
24.1x
P/E 2027 * 21.2x
Enterprise Value 32TCr 28TCr 26TCr 24TCr 45TCr 30,34300Cr 46TCr 3,07400Cr 1,19500Cr 14,91500Cr 1,19600Cr 1,17100Cr 51,39700Cr EV / Sales 2026 *
5.03x
EV / Sales 2027 * 4.65x
Free-Float
96.63%
Yield 2026 *
1.73%
Yield 2027 * 1.82%
1 day+6.14%
Current month+110.36%
6 months+113.93%
Current year+112.28%
Current year 89.04
Extreme 89.04
196.41
1 year 68.62
Extreme 68.615
196.41
3 years 60.47
Extreme 60.47
196.41
5 years 52.65
Extreme 52.65
196.41
10 years 25.55
Extreme 25.55
196.41
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Compliance Officer - 01/01/2023
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
+6.14%+5.10% - - 30TCr
+1.86%+0.48%+55.50%+163.08% 1,08200Cr
+3.57%+3.29%+68.60%+61.03% 63TCr
+3.99%+3.05%+37.93%+93.37% 46TCr
+3.86%+1.64%+32.57%+24.89% 34TCr
-0.08%+1.30%+32.15%+44.48% 29TCr
-1.54%+2.81%-25.35%-39.61% 22TCr
+3.55%+4.41%+25.45%+66.28% 20TCr
+4.21%+2.65%+17.47%+71.11% 16TCr
+1.84%+0.12%-4.18%-33.64% 14TCr
Average +2.74%+4.78%+26.68%+50.11% 39.24TCr
Weighted average by Cap. +2.75%+5.81%+40.54%+82.44%

Financials

2026 *2027 *
Net sales 6.33TCr 5.54TCr 5.09TCr 4.74TCr 8.99TCr 6,03000Cr 9.13TCr 61TCr 24TCr 2,96400Cr 24TCr 23TCr 10,21300Cr 6.7TCr 5.86TCr 5.38TCr 5.02TCr 9.51TCr 6,37700Cr 9.66TCr 65TCr 25TCr 3,13500Cr 25TCr 25TCr 10,80200Cr
Net income 1.25TCr 1.09TCr 1TCr 933.37Cr 1.77TCr 1,18700Cr 1.8TCr 12TCr 4.67TCr 58TCr 4.68TCr 4.58TCr 2,01000Cr 1.4TCr 1.22TCr 1.12TCr 1.05TCr 1.98TCr 1,33000Cr 2.01TCr 13TCr 5.24TCr 65TCr 5.24TCr 5.13TCr 2,25300Cr
Net Debt 1.93TCr 1.68TCr 1.55TCr 1.44TCr 2.74TCr 1,83500Cr 2.78TCr 19TCr 7.23TCr 90TCr 7.23TCr 7.08TCr 3,10800Cr 1.21TCr 1.06TCr 969.72Cr 903.89Cr 1.71TCr 1,14900Cr 1.74TCr 12TCr 4.53TCr 56TCr 4.53TCr 4.43TCr 1,94700Cr
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
02/26/02 $195.15 +6.14% 23,79,658
01/26/01 $183.86 -3.04% 21,15,467
30/26/30 $189.62 -0.70% 25,98,709
29/26/29 $190.95 +1.35% 16,44,471
26/26/26 $188.41 +1.47% 32,35,391
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
193.04USD
Average target price
217.82USD
Spread / Average Target
+12.83%

Quarterly revenue - Rate of surprise